Question 1

What is Memantine?

Accepted Answer

Memantine is a medication classified as an NMDA receptor antagonist that targets chemical activity in the brain. It functions by regulating the activity of glutamate, a chemical messenger that is essential for processing and retrieving information.

The medication is intended to support cognitive function and daily activities by balancing these chemical signals. It does not cure the underlying causes of neurological symptoms but aims to help improve functional abilities and awareness.

Question 2

What is Memantine used for?

Accepted Answer

Memantine is used to treat moderate to severe Alzheimer disease .

Question 3

How does Memantine work?

Accepted Answer

Regulating Glutamate

Memantine belongs to a class of medications called NMDA receptor antagonists. It works by managing the activity of glutamate, a neurotransmitter that sends signals between nerve cells. In a healthy brain, glutamate is released in specific amounts to help the brain process, store, and retrieve information.

Protecting Nerve Cells

In people with moderate-to-severe Alzheimer's disease, the brain may produce too much glutamate. When glutamate levels are excessively high, it can overstimulate nerve cells. This constant overstimulation creates background noise that makes it difficult for the brain to process clear signals and can eventually lead to nerve cell damage or death.

Memantine helps by:

Blocking NMDA receptors to prevent them from being over-activated by excess glutamate.

Reducing the background noise so that important signals can be detected more easily by the brain.

Protecting nerve cells from the damage caused by chronic overstimulation.

By stabilizing glutamate activity, memantine may help improve memory, awareness, and the ability to perform daily tasks. It is important to note that while memantine treats the symptoms of Alzheimer's disease, it is not a cure and does not stop the underlying progression of the condition.

Question 4

What are the brand names for Memantine?

Accepted Answer

Memantine is sold under the brand names Namenda , Axura , and Ebixa .

Question 5

What are the active ingredients in Memantine?

Accepted Answer

The active ingredient in Memantine is memantine .

Question 6

What are the side effects of Memantine?

Accepted Answer

Common side effects of Memantine may include:

dizziness

headache

confusion

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Memantine?

Accepted Answer

Memantine belongs to the NMDA receptor antagonist drug class.

Question 8

What is the dosage of Memantine and how do I take it?

Accepted Answer

How to Take Memantine

Memantine is available as a standard tablet, an extended-release capsule, and an oral solution. It can be taken with or without food. Your healthcare provider will typically start you on a low dose and gradually increase it over several weeks to help your body adjust to the medication.

Administration Instructions

Tablets and Oral Solution: These forms are generally taken once or twice a day. If you are using the liquid oral solution, use the specific dosing syringe or measuring device provided with the medicine to ensure the correct amount.

Extended-Release Capsules: These are usually taken once daily. They should be swallowed whole and must not be crushed or chewed. If you have difficulty swallowing the capsule, it may be opened and the contents sprinkled onto a spoonful of applesauce. The mixture should be swallowed immediately without chewing.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take extra medicine or two doses at once to make up for a missed dose. If you miss several days of treatment, contact your doctor for instructions before you start taking the medication again.

Question 9

Is Memantine safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate or well-controlled studies on the use of memantine in pregnant women. Animal studies have shown some evidence of developmental toxicity when the drug was administered at doses that also caused toxicity in the mother. Because human data is lacking, memantine should only be used during pregnancy if the potential benefit to the patient outweighs the potential risk to the fetus.

Breastfeeding

It is not known whether memantine passes into human breast milk. Many medications are excreted in breast milk, and the potential for adverse effects in a nursing infant is unknown. Healthcare providers typically advise caution when considering the use of memantine while breastfeeding.

If you are pregnant, planning to become pregnant, or breastfeeding, consult with a healthcare professional to determine the safest course of treatment.

Question 10

What forms and strengths does Memantine come in?

Accepted Answer

Oral Tablets

Memantine is available as immediate-release tablets. These are typically prescribed to be taken twice per day.

Extended-Release Capsules

Extended-release capsules are formulated to release the medication into the body gradually. This form is usually taken once daily. For individuals who have trouble swallowing, the capsules can be opened and the contents sprinkled onto a small amount of applesauce.

Oral Solution

A liquid oral solution is available for those who prefer or require a liquid format. This form is typically taken twice daily and should be measured using the specific dosing device provided with the medication.

Question 11

What is the FDA approval status of Memantine?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved memantine for the treatment of moderate to severe dementia of the Alzheimer's type. It is intended to help manage symptoms of the disease but is not a cure for the underlying condition.

Regulatory Status

Prescription Requirement: Memantine is available only with a prescription from a licensed healthcare provider.

Boxed Warnings: There are no FDA boxed warnings associated with memantine.

REMS: The FDA does not require a Risk Evaluation and Mitigation Strategy (REMS) for this medication.

Approved Formulations

The FDA has approved several versions of memantine, including immediate-release tablets, extended-release capsules, and an oral solution. Additionally, a combination product containing both memantine and donepezil is FDA-approved for patients with moderate to severe Alzheimer's disease who are already stabilized on specific doses of both individual medications.

Question 12

What should I know about Memantine and cost?

Accepted Answer

Generic Availability

Memantine is available as a generic medication. Generic versions are typically much less expensive than brand-name products. Because memantine is often used for long-term treatment of Alzheimer's disease, choosing a generic version can result in significant savings over time.

Insurance and Medicare Coverage

Most Medicare Part D plans and private health insurance policies cover memantine, particularly in its generic form. The specific out-of-pocket cost depends on the insurance plan's formulary, the patient's deductible, and the specific copayment or coinsurance requirements.

Factors Affecting Retail Price

Several factors can influence the cost of memantine at the pharmacy:

Formulation: The price may vary depending on whether the medication is prescribed as an immediate-release tablet, an extended-release capsule, or an oral solution.

Pharmacy Selection: Prices can differ between retail pharmacies, and some may offer lower prices through mail-order programs.

Prescription Size: Obtaining a larger supply, such as a 90-day prescription, may reduce the overall cost per dose compared to a 30-day supply.

Memantine

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?